2024 ICD-10-CM Diagnosis Code A30.3

by

Borderline leprosy

  • A30.3 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2024 edition of ICD-10-CM A30.3 became effective on October 1, 2023.
  • This is the American ICD-10-CM version of A30.3 – other international versions of ICD-10 A30.3 may differ.

Applicable To

  • BB leprosy

The following code(s) above A30.3 contain annotation back-references

 that may be applicable to A30.3:

  • A00-B99  Certain infectious and parasitic diseases
  • A30  Leprosy [Hansen’s disease]

Approximate Synonyms

  • Borderline hansen’s disease (leprosy)

Clinical Information

  • A form of leprosy in which there are clinical manifestations of both principal types (lepromatous and tuberculoid). The disease may shift toward one of these two polar or principal forms.

ICD-10-CM A30.3 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):

  • 867 Other infectious and parasitic diseases diagnoses with mcc
  • 868 Other infectious and parasitic diseases diagnoses with cc
  • 869 Other infectious and parasitic diseases diagnoses without cc/mcc

Convert A30.3 to ICD-9-CMCode History

  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
  • 2024 (effective 10/1/2023): No change

Diagnosis Index entries containing back-references to A30.3:

  • Leprosy
    • borderline (infiltrated) (neuritic) A30.3
    • BB A30.3
    • dimorphous A30.3 (infiltrated) (neuritic)
    • mixed A30.3
    • primary neuritic A30.3